v3.21.1
Segment Information (Tables)
3 Months Ended
Apr. 02, 2021
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The Company’s segment results were as follows:
Three Months Ended
April 2, 2021April 3, 2020
(In thousands)
Net sales:
     Fabrication Technology$568,128 $525,537 
Medical Technology311,083 290,819 
$879,211 $816,356 
Segment operating income (loss)(1):
     Fabrication Technology$82,305 $69,036 
Medical Technology2,162 3,804 
     Corporate and other(17,361)(14,078)
$67,106 $58,762 
(1) Following is a reconciliation of Income from continuing operations before income taxes to segment operating income:
Three Months Ended
April 2, 2021April 3, 2020
(In thousands)
Income from continuing operations before income taxes$35,647 $22,041 
Interest expense, net25,660 24,796 
Restructuring and other related charges(1)
4,046 11,025 
MDR and other costs(2)
1,753 900 
Segment operating income$67,106 $58,762 
(1) Restructuring and other related charges includes $1.8 million of expense classified as Cost of sales on the Company’s Condensed Consolidated Statements of Operations for the three months ended April 3, 2020, only.
(2) Primarily related to costs specific to compliance with medical device reporting regulations and other requirements of the European Union Medical Device Regulation of 2017.